KASSIE SIMMONS: Open Payments
NPI 1013542315 · CHADBOURN, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$404 in 20 payments from 9 companies in 2025. Trend: 2023 $206 · 2024 $241 · 2025 $404
Food & beverage: $404
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 4 | $85 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $68 |
| Ardelyx, Inc. | 3 | $66 |
| Novo Nordisk Inc | 2 | $46 |
| ABBVIE INC. | 2 | $36 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| Viatris Specialty LLC | 2 | $32 |
| Amgen Inc. | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 1 | $17 |
Products named: REXULTI, CAPLYTA, IBSRELA, Ozempic, YUPELRI, OTEZLA, QULIPTA, UBRELVY.
Industry payments across NC — which companies pay providers there.
